We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Lipids and Lipid Disorders
 201-220 of 406 Articles
Original Investigation |  FREE
Anne E. Sumner, MD; Karl B. Finley, MD; David J. Genovese, RN; et al.
Arch Intern Med. 2005;165(12):1395-1400. doi:10.1001/archinte.165.12.1395.

Original Investigation |  FREE
Paul K. Whelton, MD, MSc; Joshua Barzilay, MD; William C. Cushman, MD; et al.
Arch Intern Med. 2005;165(12):1401-1409. doi:10.1001/archinte.165.12.1401.

Original Investigation |  FREE
Richard H. Chapman, PhD; Joshua S. Benner, PharmD, ScD; Allison A. Petrilla, BA; et al.
Arch Intern Med. 2005;165(10):1147-1152. doi:10.1001/archinte.165.10.1147.

Original Investigation |  FREE
Alexander Tenenbaum, MD, PhD; Michael Motro, MD; Enrique Z. Fisman, MD; et al.
Arch Intern Med. 2005;165(10):1154-1160. doi:10.1001/archinte.165.10.1154.

Original Investigation |  FREE
Abel E. Moreyra, MD; Alan C. Wilson, PhD; Ashraf Koraym, MD
Arch Intern Med. 2005;165(10):1161-1166. doi:10.1001/archinte.165.10.1161.

Original Investigation |  FREE
Chung-Jyi Tsai, MD, ScD; Michael F. Leitzmann, MD, DrPH; Walter C. Willett, MD, DrPH; et al.
Arch Intern Med. 2005;165(9):1011-1015. doi:10.1001/archinte.165.9.1011.

Original Investigation |  FREE
C. Alex McMahan, PhD; Samuel S. Gidding, MD; Zahi A. Fayad, PhD; et al.
Arch Intern Med. 2005;165(8):883-890. doi:10.1001/archinte.165.8.883.

Review Article |  FREE
Marco Studer, MD; Matthias Briel, MD; Bernd Leimenstoll, MD; et al.
Arch Intern Med. 2005;165(7):725-730. doi:10.1001/archinte.165.7.725.

Original Investigation |  FREE
Rachel H. Mackey, PhD, MPH; Lewis H. Kuller, MD, DrPH; Kim Sutton-Tyrrell, DrPH; et al.
Arch Intern Med. 2005;165(5):510-515. doi:10.1001/archinte.165.5.510.

Special Article | 
Daniel J. Brotman, MD; Esteban Walker, PhD; Michael S. Lauer, MD; et al.
Arch Intern Med. 2005;165(2):138-145. doi:10.1001/archinte.165.2.138.

Original Investigation |  FREE
Kari L. Olson, PharmD, BCPS; Jon Rasmussen, PharmD, BCPS; Brian G. Sandhoff, PharmD, BCPS; et al.
Arch Intern Med. 2005;165(1):49-54. doi:10.1001/archinte.165.1.49.

Original Investigation |  FREE
Joel G. Ray, MD, MSc; Yanyan Gong, MSc; Kathy Sykora, MSc; et al.
Arch Intern Med. 2005;165(1):62-67. doi:10.1001/archinte.165.1.62.

Editor's Correspondence | 
Roberto Manfredini, MD; Benedetta Boari, MD
Arch Intern Med. 2004;164(22):2500-2509. doi:10.1001/archinte.164.22.2505-a.

Editor's Correspondence | 
William T. Donahoo, MD; Robert H. Eckel, MD
Arch Intern Med. 2004;164(22):2500-2509. doi:10.1001/archinte.164.22.2506-a.

Editor's Correspondence | 
Ira S. Ockene, MD; David E. Chiriboga, MD, MPH; Edward J. Stanek III, PhD; et al.
Arch Intern Med. 2004;164(22):2500-2509. doi:10.1001/archinte.164.22.2506-b.

Original Investigation |  FREE
Sarah S. Knox, PhD; Gerdi Weidner, PhD; Avril Adelman, MA; et al.
Arch Intern Med. 2004;164(22):2442-2447. doi:10.1001/archinte.164.22.2442.

Original Investigation |  FREE
Richard W. Grant, MD, MPH; Kathleen M. O’Leary, BA; Jeffrey B. Weilburg, MD; et al.
Arch Intern Med. 2004;164(21):2343-2348. doi:10.1001/archinte.164.21.2343.

Original Investigation |  FREE
Y. Wady Aude, MD; Arthur S. Agatston, MD; Francisco Lopez-Jimenez, MD, MSc; et al.
Arch Intern Med. 2004;164(19):2141-2146. doi:10.1001/archinte.164.19.2141.

Original Investigation |  FREE
Frederick A. Spencer, MD; Gregg C. Fonarow, MD; Paul D. Frederick, MPH, MBA; et al.
Arch Intern Med. 2004;164(19):2162-2168. doi:10.1001/archinte.164.19.2162.

Review Article |  FREE
Jack Hirsh, CM, MD, FRCPC, FRACP, FRSC, DSc; Deepak L. Bhatt, MD, FACC, FSCAI, FESC
Arch Intern Med. 2004;164(19):2106-2110. doi:10.1001/archinte.164.19.2106.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
From The Medical Letter on Drugs and Therapeutics  | 
Alirocumab (Praluent) to Lower LDL-Cholesterol

Clinical Trials Update  | 
Antisense Inhibitor Lowers High Triglycerides
Anita Slomski, MA
Original Investigation  | 
Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease A Randomized Clinical Trial
Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; et al.
News From the Food and Drug Administration  | 
New Drug to Lower LDL Cholesterol
Rebecca Voelker, MSJ